Development and Characterisation of a Human Chronic Skin Wound Cell Line-Towards an Alternative for Animal Experimentation
- PMID: 29584680
- PMCID: PMC5979489
- DOI: 10.3390/ijms19041001
Development and Characterisation of a Human Chronic Skin Wound Cell Line-Towards an Alternative for Animal Experimentation
Abstract
Background: Chronic skin wounds are a growing financial burden for healthcare providers, causing discomfort/immobility to patients. Whilst animal chronic wound models have been developed to allow for mechanistic studies and to develop/test potential therapies, such systems are not good representations of the human chronic wound state. As an alternative, human chronic wound fibroblasts (CWFs) have permitted an insight into the dysfunctional cellular mechanisms that are associated with these wounds. However, such cells strains have a limited replicative lifespan and therefore a limited reproducibility/usefulness. Objectives: To develop/characterise immortalised cell lines of CWF and patient-matched normal fibroblasts (NFs). Methods and Results: Immortalisation with human telomerase resulted in both CWF and NF proliferating well beyond their replicative senescence end-point (respective cell strains senesced as normal). Gene expression analysis demonstrated that, whilst proliferation-associated genes were up-regulated in the cell lines (as would be expected), the immortalisation process did not significantly affect the disease-specific genotype. Immortalised CWF (as compared to NF) also retained a distinct impairment in their wound repopulation potential (in line with CWF cell strains). Conclusions: These novel CWF cell lines are a credible animal alternative and could be a valuable research tool for understanding both the aetiology of chronic skin wounds and for therapeutic pre-screening.
Keywords: animal alternative; chronic wound; fibroblasts; microarray; wound healing.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
An analysis of replicative senescence in dermal fibroblasts derived from chronic leg wounds predicts that telomerase therapy would fail to reverse their disease-specific cellular and proteolytic phenotype.Exp Cell Res. 2003 Feb 1;283(1):22-35. doi: 10.1016/s0014-4827(02)00021-6. Exp Cell Res. 2003. PMID: 12565817
-
Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers.J Invest Dermatol. 2008 Oct;128(10):2526-40. doi: 10.1038/jid.2008.114. Epub 2008 May 1. J Invest Dermatol. 2008. PMID: 18449211
-
Time- and dose-dependent effects of chronic wound fluid on human adult dermal fibroblasts.Dermatol Surg. 2008 Mar;34(3):347-56. doi: 10.1111/j.1524-4725.2007.34068.x. Epub 2007 Dec 20. Dermatol Surg. 2008. PMID: 18177397
-
Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.J Biomed Mater Res A. 2015 Dec;103(12):3993-4023. doi: 10.1002/jbm.a.35515. Epub 2015 Aug 14. J Biomed Mater Res A. 2015. PMID: 26034007 Review.
-
Alternatives for animal wound model systems.Methods Mol Biol. 2013;1037:177-201. doi: 10.1007/978-1-62703-505-7_10. Methods Mol Biol. 2013. PMID: 24029936 Review.
Cited by
-
Oral Progenitor Cell Line-Derived Small Extracellular Vesicles as a Treatment for Preferential Wound Healing Outcome.Stem Cells Transl Med. 2022 Aug 23;11(8):861-875. doi: 10.1093/stcltm/szac037. Stem Cells Transl Med. 2022. PMID: 35716044 Free PMC article.
-
New Innovations in Wound Healing and Repair.Int J Mol Sci. 2019 Apr 8;20(7):1724. doi: 10.3390/ijms20071724. Int J Mol Sci. 2019. PMID: 30965550 Free PMC article.
-
Assessing Animal Models to Study Impaired and Chronic Wounds.Int J Mol Sci. 2024 Mar 29;25(7):3837. doi: 10.3390/ijms25073837. Int J Mol Sci. 2024. PMID: 38612647 Free PMC article. Review.
-
Inhibition of Th2 Differentiation Accelerates Chronic Wound Healing by Facilitating Lymphangiogenesis.Biomedicines. 2025 Apr 24;13(5):1026. doi: 10.3390/biomedicines13051026. Biomedicines. 2025. PMID: 40426856 Free PMC article.
-
Human In Vitro Skin Models for Wound Healing and Wound Healing Disorders.Biomedicines. 2023 Mar 30;11(4):1056. doi: 10.3390/biomedicines11041056. Biomedicines. 2023. PMID: 37189674 Free PMC article. Review.
References
-
- Kuehn B.M. Chronic wound care guidelines issued. JAMA. 2007;297:938–939. - PubMed
-
- Budgen V. Evaluating the impact on patients of living with a leg ulcer. Nurs. Times. 2004;100:30–31. - PubMed
-
- Iglesias C.P., Birks Y., Nelson E.A., Scanlon E., Cullum N.A. Quality of life of people with venous leg ulcers: A comparison of the discriminative and responsive characteristics of two generic and a disease specific instruments. Qual. Life Res. 2005;14:1705–1718. doi: 10.1007/s11136-005-2751-9. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials